<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A2A67F27-6090-418D-A6F0-2F1B3A93EE30"><gtr:id>A2A67F27-6090-418D-A6F0-2F1B3A93EE30</gtr:id><gtr:name>Oxford Mestar Limited</gtr:name><gtr:address><gtr:line1>30 UPPER HIGH STREET</gtr:line1><gtr:city>THAME</gtr:city><gtr:postCode>OX9 3EZ</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Engineering Science</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A2A67F27-6090-418D-A6F0-2F1B3A93EE30"><gtr:id>A2A67F27-6090-418D-A6F0-2F1B3A93EE30</gtr:id><gtr:name>Oxford Mestar Limited</gtr:name><gtr:address><gtr:line1>30 UPPER HIGH STREET</gtr:line1><gtr:city>THAME</gtr:city><gtr:postCode>OX9 3EZ</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BA02D199-DCEA-4F8A-B0A8-518F210C47A7"><gtr:id>BA02D199-DCEA-4F8A-B0A8-518F210C47A7</gtr:id><gtr:name>Chang Gung University</gtr:name><gtr:address><gtr:line1>259 Wen Hwa</gtr:line1><gtr:line2>Kwei Shan</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Taiwan, Province of China</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/80C49C08-D611-4583-A18D-7EEB2EBD0BCB"><gtr:id>80C49C08-D611-4583-A18D-7EEB2EBD0BCB</gtr:id><gtr:firstName>Zhanfeng</gtr:firstName><gtr:surname>Cui</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FL003961%2F1"><gtr:id>0614FAF3-53BC-49EA-BA85-5E1BE3521EBE</gtr:id><gtr:title>Development of a high-throughput perfused three dimensional cell culture platform for stem cell study and drug testing</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L003961/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2015-09-13</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-09-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>24990</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford MeStar Limited</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MeStar</gtr:description><gtr:id>6748B1BC-9F0F-4E5A-B826-D809E4B63162</gtr:id><gtr:impact>PMID: 24184152
PMID: 23977329
PMID: 21976446</gtr:impact><gtr:outcomeId>56d47a2e28b0a1.64641364-1</gtr:outcomeId><gtr:partnerContribution>My partner, Oxford MeStar Limited has contributed 90,000 pounds for research that develops enabling technologies for tissue engineering and stem cell therapy. This company has core technical expertise in bioprocessing, bioengineering and bio-manufacture.</gtr:partnerContribution><gtr:piContribution>I/my team are conducting research projects in translational and regenerative medicine, in particular developing enabling technologies for stem cell therapy.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>A new drug testing platform based on advanced cell based assays was established and ready to be used in industry. The project also promoted collaboration between UK and Taiwan.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>C512E9D5-22BC-4F83-B748-883E5CCBC0B5</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d733e9d509c0.26583552</gtr:outcomeId><gtr:sector>Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Through the project, we improved two aspects related to microbioreactor technology - (i) increased throughput, so to increase productivity, (ii) introduced automation, to make the equipment more user friendly. Case studies using different cell platforms were published to show the efficacy.</gtr:description><gtr:exploitationPathways>Industry in Taiwan and China are exploring to commercialise the technology.</gtr:exploitationPathways><gtr:id>76FEEC9F-CAE9-4371-A8AF-AD4FB88DAD72</gtr:id><gtr:outcomeId>56d734c8b9f9a8.01139887</gtr:outcomeId><gtr:sectors><gtr:sector>Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F8DAE272-92C3-40D3-9C3E-60BA0E6F0658</gtr:id><gtr:title>Layering PLGA-based electrospun membranes and cell sheets for engineering cartilage-bone transition.</gtr:title><gtr:parentPublicationTitle>Journal of tissue engineering and regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f789b71204866025002bedacd771f77"><gtr:id>5f789b71204866025002bedacd771f77</gtr:id><gtr:otherNames>Mouthuy PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6254</gtr:issn><gtr:outcomeId>56d4541a3e0e96.96984687</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F946FD71-45F5-48FA-AA98-B23D28611CAD</gtr:id><gtr:title>A multi-paradigm modeling framework to simulate dynamic reciprocity in a bioreactor.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88325f5ad15e0a7fccad8bf4fbcc4986"><gtr:id>88325f5ad15e0a7fccad8bf4fbcc4986</gtr:id><gtr:otherNames>Kaul H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d4541a989db8.32169467</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14B879B4-B737-4A27-BC25-0E0FFC37EC3C</gtr:id><gtr:title>4th Annual Predictive Toxicology Summit 2012.</gtr:title><gtr:parentPublicationTitle>Expert opinion on drug metabolism &amp; toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d97ea2d68ad8a609028c2140f7cd553c"><gtr:id>d97ea2d68ad8a609028c2140f7cd553c</gtr:id><gtr:otherNames>Cui Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-5255</gtr:issn><gtr:outcomeId>56d4541a6704c0.96923658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15985E9E-7344-4C28-93F1-E2E970F2896A</gtr:id><gtr:title>Three-dimensional perfused cell culture.</gtr:title><gtr:parentPublicationTitle>Biotechnology advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4e3979f177e6ad9e72d3a5c818988a"><gtr:id>5a4e3979f177e6ad9e72d3a5c818988a</gtr:id><gtr:otherNames>Li Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0734-9750</gtr:issn><gtr:outcomeId>56d45419ddf7b6.47025153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7A35E4A-125D-4EC3-9213-7AB2C33F7300</gtr:id><gtr:title>Development of in vitro 3D TissueFlex&amp;reg; islet model for diabetic drug efficacy testing.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4e3979f177e6ad9e72d3a5c818988a"><gtr:id>5a4e3979f177e6ad9e72d3a5c818988a</gtr:id><gtr:otherNames>Li Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d4541a174ee8.49615952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>793D8280-7CEC-434F-9076-C4E98600F0F0</gtr:id><gtr:title>Three-dimensional perfused tumour spheroid model for anti-cancer drug screening.</gtr:title><gtr:parentPublicationTitle>Biotechnology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fcba9da379854e7b1d4e580386d825b"><gtr:id>4fcba9da379854e7b1d4e580386d825b</gtr:id><gtr:otherNames>Wan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0141-5492</gtr:issn><gtr:outcomeId>58b6cf169d9874.21598605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EEC668A-5DF0-484D-A111-F00CF93F8B59</gtr:id><gtr:title>A polyhedral oligomeric silsesquioxane-based bilayered dermal scaffold seeded with adipose tissue-derived stem cells: in&amp;nbsp;vitro assessment of biomechanical properties.</gtr:title><gtr:parentPublicationTitle>The Journal of surgical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe3f73676d355880689f2a6f4e80524f"><gtr:id>fe3f73676d355880689f2a6f4e80524f</gtr:id><gtr:otherNames>Chawla R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-4804</gtr:issn><gtr:outcomeId>56d45ab0d38714.53675468</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L003961/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>